Patterson Belknap secured a dismissal on behalf of its client, The Coca-Cola Company, in a consumer fraud case brought by an environmental group.
Patterson Belknap has launched an interdisciplinary FTX Task Force to advise market participants navigating the fallout from the recent collapse of the FTX Crypto Exchange and its affiliates.
Patterson Belknap secured a settlement on behalf of its client, Ambac Assurance Corporation, in a series of lawsuits against Bank of America entities, including Countrywide (which Bank of America acquired in 2008), related to residential mortgage backed securities insured by Ambac.
Patterson Belknap has again been ranked as a leading law firm by Euromoney Institutional Investor PLC's Benchmark Litigation in the top category, "Highly Recommended," for New York Dispute Resolution.
Litigation Partner Adeel Mangi has been named to Benchmark Litigation's2023 "Top 100 Trial Lawyers,” an exclusive list of the top trial lawyers in the United States.
Patterson Belknap is pleased to announce that Joshua A. Goldberg will serve as Chair of the firm’s Litigation department, a group of more than 125 lawyers.
Patterson Belknap partner Peter C. Harvey was appointed by National Football League (NFL) Commissioner Roger Goodell to hear the appeal of the six-game suspension of Cleveland Browns quarterback Deshaun Watson for violating the league’s personal conduct policy.
Litigation partner Muhammad Faridi has been named to 2022 edition of Bloomberg Law's "They've got Next: The 40 Under 40" list.
Litigation Partners Muhammad U. Faridi, Joshua Kipnees, Jane Metcalf, Lauren Potter, Rachel Sherman, Stephanie Teplin, and Jason Vitullo have been named to Benchmark Litigation’s 2022 “40 & Under List.”
Patterson Belknap has once again been included on The American Lawyer’s 2022 “A-List” of 20 leading law firms in the United States, this year receiving a ranking of #14.
On July 19, 2022, the New York State Appellate Division, First Department, ruled in favor of our client, a Fortune 100 pharmaceutical and consumer goods company, reversing a $325 million dollar jury award and dismissing a product liability case relating to cosmetic talcum powder.
Patterson Belknap received the #2 ranking nationally in Vault’s 2023 “Best Law Firms for Pro Bono” list. The Firm also ranked #5 nationally on The American Lawyer’s 2022 Pro Bono Scorecard.
Patterson Belknap Webb & Tyler LLP is pleased to announce that the Firm was recognized by Chambers High Net Worth 2022 in the Art and Cultural Property Law – USA practice area. In addition, Jo Backer Laird and John Sare were ranked in the Art and Cultural Property Law practice area in the USA. Anne-Laure Alléhaut was also recognized.
Partner Muhammad Faridi was recognized by Crain’s New York Business as one of its 2022 Notable Diverse Leaders in Law, a list comprising 80 individuals who "excel in their practice" and "stand out for their counseling and the nature of their pro bono work."
Patterson Belknap Webb & Tyler LLP is pleased to announce that six of our practice areas and fourteen of our partners and counsel received recognition in the newly released Chambers USA - America’s Leading Lawyers for Business 2022.
Patterson Belknap Webb & Tyler LLP is pleased to announce that Kito Huggins has been appointed Chief Diversity, Equity and Inclusion Officer. In this capacity, he will design and deploy strategies which further strengthen the Firm’s diverse and inclusive culture in close collaboration with, and as a member of, its senior leadership team.
On Monday, May 9, a jury in Fairfax County, Virginia, awarded our client, Appian Corporation, $2.036 billion in damages from Pegasystems Inc. for trade secret misappropriation following a seven-week trial.
Partner Muhammad Faridi was appointed to serve on the New York City Mayor's Advisory Committee on the Judiciary (“MACJ”). As a member of the Committee, Mr. Faridi will help “ensure that only candidates with the highest qualifications and from diverse backgrounds are nominated for judicial appointments to criminal and family courts, as well as interim appointments to civil court.”
Patterson Belknap achieved a victory on behalf of Allbirds, Inc. in a putative consumer class action challenging the advertising of wool shoes. The plaintiff alleged that Allbirds misrepresents its standards for sustainability and animal welfare, and our team moved to dismiss the complaint on the grounds that the company’s statements are truthful and not misleading to reasonable consumers.
Ruling from the bench after oral argument on April 4, 2022, Justice Joel M. Cohen of the New York Supreme Court denied a motion to dismiss a breach-of-contract claim asserted by our client, Freedom Trust 2011-2 (“Freedom Trust”), against HSBC Bank USA, N.A. (“HSBC”).
Patterson Belknap Webb & Tyler LLP is pleased to announce that the firm has elected Dahlia B. Doumar as Co-Chair and Managing Partner, effective immediately. She succeeds Lisa E. Cleary, who served as Co-Chair and Managing Partner for eight years, and joins Peter W. Tomlinson, who has been re-elected for an additional term as Co-Chair.
Partner Peter Harvey was selected as a member of the National Football League’s (“NFL”) Diversity Advisory Committee. The NFL established the committee to review league and club policies to address concerns over the lack of diversity in the hiring of head coaches and senior executives within the NFL’s teams. The new committee aims to help build a more inclusive league.
Patterson Belknap Webb & Tyler LLP is pleased to announce that intellectual property attorney Stephanie Bunting Glaser has become Counsel to the Firm, and employee benefits and executive compensation attorney Jessica S. Carter has become Special Counsel.
Patterson Belknap partner Alejandro Cruz has been selected as the Firm’s Leadership Council on Legal Diversity (LCLD) Fellow for 2022, while associate Christina Seda-Acosta has been selected as the Firm’s 2022 LCLD Pathfinder.
Patterson Belknap Webb & Tyler LLP is pleased to announce that six of our attorneys were recognized as “Client Service All-Stars 2022” by The BTI Consulting Group.
For the ninth consecutive year, Patterson Belknap has been recognized by the Human Rights Campaign Foundation as a “Best Place to Work” for LGBTQ+ workplace equality. The Firm scored a 100% rating in HRC’s newly released 2022 Corporate Equality Index (CEI) report.
Patterson Belknap has been shortlisted for Benchmark Litigation’s 2022 U.S. Awards for the New York category. According to Benchmark, these annual awards “recognize the country’s most distinguished litigators and their firms for their exemplary work over the past twelve months.
Patterson Belknap’s Anti-Counterfeiting and Brand Protection team, led by Geoffrey Potter, executed seizures at 17 locations in nine states, seizing thousands of bottles of counterfeit HIV medicine on behalf of an American biopharmaceutical company.
On January 11, 2022, the Firm secured dismissal of breach of contract claims in a putative class action filed by a proposed class of textbook authors against our client, a major educational publisher and technology firm, in New York federal court alleging that our client denied the textbook authors royalties from digital sales.
Patterson Belknap Webb & Tyler LLP today announced the launch of Securities Litigation Insider, a blog covering a wide range of topics relevant to securities litigation, including notable developments such as U.S. Securities and Exchange Commission (SEC) enforcement, SEC rulemaking, securities class actions, and developments in blockchain and crypto-asset regulation, among other areas.
Patterson Belknap Webb & Tyler LLP is pleased to announce that, effective January 1, 2022, Douglas L. Tang, Amy N. Vegari, and Timothy A. Waters will become partners of the Firm, and Susan M. Vignola, Lisa Wang, and Justin Zaremby will become counsel.
The Firm obtained a significant trial victory for our client, Johnson & Johnson (J&J) subsidiaries Janssen Pharmaceuticals, Inc. and Janssen Pharmaceutica, NV, when the U.S. District Court for the District of New Jersey issued an order in our client’s favor in a Hatch-Waxman patent litigation.
Partner Barbara Mullin was selected as The American Lawyer’s ‘Litigator of the Week’ for securing a significant trial victory for Johnson & Johnson (J&J) subsidiaries Janssen Pharmaceuticals, Inc. and Janssen Pharmaceutica, NV, when the U.S. District Court for the District of New Jersey issued an order in J&J’s favor in a Hatch-Waxman patent litigation.
On November 4, 2021, the Firm secured a significant victory for our commercial real estate clients Security National Properties Holding Company, LLC and related entities (collectively, “SNP”) in an appeal filed in the First Department of the Appellate Division of New York State Supreme Court.
Last week, the Firm secured the voluntary dismissal of a lawsuit brought against our client, the National Baseball Hall of Fame and Museum, by former New York Yankee Joe Pepitone in the U.S. District Court for the Northern District of New York.
On Thursday, October 7, the Firm secured a significant victory for our client, a major medical device manufacturer, when the U.S. Court of Appeals for the Ninth Circuit affirmed October 21, 2019 and August 17, 2020 decisions issued by the U.S. District Court for the Southern District of California, granting our client two summary judgment wins in a false advertising dispute.
Patterson Belknap has again been ranked as a leading law firm by Euromoney Institutional Investor PLC's Benchmark Litigation in the top category, "Highly Recommended," for New York Litigation.
Real Estate Partner Hope Plasha was named to the 2021 National Law Journal’s list of Real Estate/Construction Law Trailblazers. The Trailblazers award is a special supplement to the National Law Journal that spotlights professionals who are agents of change in their practice areas.
On September 3, 2021, the Firm obtained a rare ruling in the United States District Court for the Eastern District of Texas that the venue was improper for patent infringement claims brought against our client, American Express Travel Related Services Company, Inc. (“AmEx”).
On August 31, the Firm secured a significant appellate victory for The Coca-Cola Company in a long-running multi-district litigation involving the labeling of the company’s flagship beverage, Coke.
Patterson Belknap Webb & Tyler LLP ranked #11 on The American Lawyer’s 2021 “A-List” of 20 leading law firms in the United States. The 2021 “A-List,” which has just been announced, is based on five criteria: pro bono performance, associate satisfaction, diversity of lawyers, percentage of women equity partners, and financial performance.
Patterson Belknap Webb & Tyler LLP is pleased to announce that H. Gregory Baker has joined the Firm as a Partner in its Litigation department. Mr. Baker will serve as Chair of the Firm’s Securities Litigation practice and will be a member of the White Collar Defense and Investigations group.
Patterson Belknap Webb & Tyler LLP is pleased to announce that the Firm was recognized by Chambers High Net Worth 2021 in the Art and Cultural Property Law – USA practice area. Chambers rankings are based on extensive research and interviews with peers and clients around the country. The qualities assessed include technical legal ability, professional conduct, client service, commercial awareness/astuteness, diligence, commitment, and other qualities most valued by the client. In addition, Jo Backer Laird and John Sare were ranked in the Art and Cultural Property Law practice area in the USA. Anne-Laure Allehaut was also recognized.
Litigation Partners Muhammad U. Faridi, Joshua Kipnees, Jonah M. Knobler, and Jane Metcalf have been named to Benchmark Litigation’s 2021 “40 & Under Hot List.” The list recognizes practitioners who “are among the top young talent in their respective communities in the U.S. & Canada.”
On June 14, 2021, Patterson Belknap secured a significant victory for our client, McGraw Hill LLC (“McGraw Hill”), with the full dismissal of a multi-district litigation in the Southern District of New York.
Patterson Belknap Webb & Tyler LLP is pleased to announce that six of our practice areas and twelve of our partners and counsel received recognition in the newly released Chambers USA - America’s Leading Lawyers for Business 2021.
On Tuesday, April 14, 2021, the Firm obtained a significant victory for its client when the Federal Circuit affirmed a district court’s decision, following a bench trial, that our client’s blockbuster HIV drug should enter the United States duty-free. The U.S. Customs and Border Protection (“CBP”) had sought to impose duties exceeding $100 million on the drug, darunavir ethanolate, which is the drug substance in HIV medication PREZISTA®.
Patterson Belknap Webb & Tyler LLP is pleased to announce that Lauren Schorr Potter, a former Assistant United States Attorney for the Southern District of New York, has joined the Firm as a partner in the Litigation department. Ms. Potter will focus her practice on white collar defense and investigations and complex civil litigation.
Patterson Belknap has been recognized by Benchmark Litigation as the 2021 “New York Firm of the Year” and “Pro Bono Firm of the Year.”
On March 26, the Firm secured a groundbreaking victory when the U.S. District Court for the District of Delaware dismissed an enforcement action brought by the Consumer Financial Protection Bureau (“CFPB”) against fifteen student loan trusts. The decision comes in the wake of the Supreme Court’s holding last summer that the CFPB was unconstitutionally structured, which left lower courts to resolve whether the CFPB could salvage individual cases by “ratifying” its earlier decisions to bring them.
Patterson Belknap partner Daniel S. Ruzumna has been inducted as a Fellow of the American College of Trial Lawyers (ACTL), an invitation-only fellowship of exceptional trial lawyers across the United States and Canada.
On February 23, 2021, the Firm secured a settlement for our client, a multinational biotech company, in the U.S. District Court for the Northern District of Alabama. The suit accused the defendant, a group of pharmacies in Alabama, Mississippi, and Arkansas, of selling consumers thousands of boxes of our client’s blood glucose test strips that were not intended for retail sale.
On Friday, February 5, the Firm secured a settlement for our client, a Multinational Healthcare Company, when a federal judge in the U.S. District Court for the Northern District of Illinois dismissed a suit from our client against the defendant, after a consent judgment and permanent injunction was filed. The original suit accused the defendant and several employees of importing and selling dangerous and contaminated counterfeit versions of our client’s medical devices.
Patterson Belknap has been shortlisted for Benchmark Litigation’s 2021 U.S. Awards for the New York category. According to Benchmark, these annual awards “aim to recognize the firms and litigators who have performed exceptionally at both local and national levels. The shortlists are the culmination of months' research, analyzing hundreds of submissions, surveying thousands of referees and interviewing hundreds of lawyers.”